Inhibitor of mitochondrial pyruvate dehydrogenase kinase (PDK). Shifts pyruvate metabolism from glycolysis and lactate production to glucose oxidation in the mitochondria. Induces mitochondrial-dependent apoptosis and reverses the inhibition/downregulation of KV
1.5 channels in cancer but not normal cells. Decreases tumor growth in vitro
and in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex.
Bowker-kinley et al.
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.
Bonnet et al.
Cancer Cell, 2007;11:37
The pharmacology of dichloroacetate.
Metabolism Clin.Exp., 1989;38:1124